Pharma-Bio Serv (PBSV) Other Non-Current Assets (2010 - 2026)

Pharma-Bio Serv (PBSV) has reported Other Non-Current Assets for 16 consecutive years, with $120771.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets fell 46.48% year-over-year to $120771.0; the trailing twelve-month figure through Apr 2026 stood at $120771.0 (down 46.48% YoY), and the FY2025 full-year result was $120754.0, down 46.47% from the prior year.
• Other Non-Current Assets was little changed at $120771.0 in Q2 2026 per PBSV's latest filing, from $120783.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $353294.0 in Q1 2022 and bottomed at $111665.0 in Q4 2023.
• Historically, Other Non-Current Assets has averaged $171390.8 across 5 years, with a median of $130523.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets sank 63.14% in 2023, then surged 102.06% in 2025.
• Over 5 years, Other Non-Current Assets stood at $130874.0 in 2022, then decreased by 14.68% to $111665.0 in 2023, then jumped by 102.03% to $225599.0 in 2024, then tumbled by 46.47% to $120754.0 in 2025, then rose by 0.01% to $120771.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $120771.0, $120783.0, and $120754.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.